Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
BioXcel Therapeutics, Inc.
IPO Date: March 5, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $9.51M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.64 | 4.11%
Avg Daily Range (30 D): $0.09 | 4.98%
Avg Daily Range (90 D): $0.11 | 7.17%
Institutional Daily Volume
Avg Daily Volume: .68M
Avg Daily Volume (30 D): .24M
Avg Daily Volume (90 D): 3.19M
Trade Size
Avg Trade Size (Sh.): 128
Avg Trade Size (Sh.) (30 D): 240
Avg Trade Size (Sh.) (90 D): 266
Institutional Trades
Total Inst.Trades: 897
Avg Inst. Trade: $1.45M
Avg Inst. Trade (30 D): $.6M
Avg Inst. Trade (90 D): $.6M
Avg Inst. Trade Volume: M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.56M
Avg Closing Trade (30 D): $2.34M
Avg Closing Trade (90 D): $2.34M
Avg Closing Volume: 3.96K
       
News
Mar 11, 2025 @ 11:00 AM
BioXcel Therapeutics Strengthens Cash Position to ...
Source: Bioxcel Therapeutics, Inc.
Nov 21, 2024 @ 9:47 PM
BioXcel Therapeutics Announces Proposed Public Off...
Source: Globe Newswire
Nov 21, 2024 @ 9:47 PM
BioXcel Therapeutics Announces Proposed Public Off...
Source: N/A
Jul 16, 2024 @ 11:02 AM
BioXcel Therapeutics Announces Preliminary Estimat...
Source: Bioxcel Therapeutics, Inc.
Apr 24, 2024 @ 2:30 PM
BioXcel Therapeutics Announces Late-Breaking Abstr...
Source: BioXcel Therapeutics
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-23.51 $-22.22 $-23.51
Diluted EPS $-23.51 $-22.22 $-23.51
Revenue $ 2.27M $ .37M $ 2.27M
Gross Profit $ .12M $ -.47M $ .12M
Net Income / Loss $ -59.6M $ -10.86M $ -59.6M
Operating Income / Loss $ -67.25M $ -10.49M $ -67.25M
Cost of Revenue $ 2.14M $ .83M $ 2.14M
Net Cash Flow $ M $ M $ M
PE Ratio    
Splits
Feb 10, 2025:   16:1